A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The study will be a double-blind, randomized, vehicle-controlled study with application of
ruxolitinib phosphate cream or vehicle in patients with stable plaque psoriasis. Application
will be QD for 12 weeks without occlusive dressings. There will be 4 treatments of 50
subjects each.